Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
OPERATING ACTIVITIES
Net loss	$ (1,067,000)	$ (42,763,000)	$ (1,053,000)	$ (43,839,000)
Adjustments to reconcile net loss to net cash provided by operating activities:
Impairment charges				16,829,000
Straight-line rents and expenses, net			(461,000)	(4,000)
Credit adjustments on operating lease receivables			(319,000)	840,000
Depreciation and amortization			5,802,000	15,066,000
Above (below) market lease amortization, net			(128,000)	(506,000)
Expense relating to share-based compensation, net				823,000
Amortization of deferred financing costs			179,000	440,000
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:
Receivables, net			1,848,000	(1,006,000)
Deferred costs and other assets, net			(675,000)	3,659,000
Accounts payable, accrued expenses, and other liabilities			613,000	23,780,000
Net cash provided by operating activities			5,806,000	16,082,000
INVESTING ACTIVITIES
Expenditures for real estate improvements			(2,069,000)	(16,932,000)
Net proceeds from sales of real estate				31,866,000
Contributions to unconsolidated joint venture				(155,000)
Net cash (used in) provided by investing activities			(2,069,000)	14,779,000
FINANCING ACTIVITIES
Repayments under revolving credit facility				(29,000,000)
Advances under revolving credit facility				4,000,000
Mortgage repayments				(571,000)
Payments of deferred financing costs				(6,000)
Noncontrolling interests:
Distributions to limited partners				(5,000)
Acquisition of joint venture minority interest share				(1,000,000)
Preferred stock dividends			(5,376,000)	(5,376,000)
Distributions to common shareholders				(900,000)
Net cash used in financing activities			(5,376,000)	(32,858,000)
Net decrease in cash, cash equivalents and restricted cash			(1,639,000)	(1,997,000)
Cash, cash equivalents and restricted cash at beginning of period			13,463,000	3,269,000
Cash, cash equivalents and restricted cash at end of period	11,824,000	1,272,000	11,824,000	1,272,000
Reconciliation to consolidated balance sheets:
Cash and cash equivalents	1,291,000	1,042,000	1,291,000	1,042,000
Restricted cash	10,533,000	230,000	10,533,000	230,000
Cash, cash equivalents and restricted cash at end of period	$ 11,824,000	$ 1,272,000	$ 11,824,000	$ 1,272,000